AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $16.52M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
| SVY | Thursdays Gossan - New Thick Intercept in SMD016 | PRICE SENSITIVE | 20/04/18 | |
| SVY | New 124m Intercept of Porphyry M Veins | PRICE SENSITIVE | 10/04/18 | |
| SVY | Intercept of Bendigo-like Source Rocks at Toora West | PRICE SENSITIVE | 13/03/18 | |
| SVY | Thursdays Gossan - New 80m Intercept of Porphyry M Veins | PRICE SENSITIVE | 16/02/18 | |
| SVY Thursdays Gossan - New Thick Intercept in SMD016 | |||
| 20/04/18 | PRICE SENSITIVE | ||
| SVY New 124m Intercept of Porphyry M Veins | |||
| 10/04/18 | PRICE SENSITIVE | ||
| SVY Intercept of Bendigo-like Source Rocks at Toora West | |||
| 13/03/18 | PRICE SENSITIVE | ||
| SVY Thursdays Gossan - New 80m Intercept of Porphyry M Veins | |||
| 16/02/18 | PRICE SENSITIVE | ||
